Aurovitas Pharma Polska Sp. z o.o.

Aurovitas Pharma Polska, European subsidiary of Aurobindo Pharma (India), has operated in Poland since 1986 and was the third Aurovitas entity in Europe after Spain and Portugal. Following the acquisition of Apotex Polska in 2019, it offers 120+ products across 22 therapeutic areas: CVS, CNS, GI, antibiotics, respiratory, antidiabetics, oncology, and OTC. Since 2020, it operates its own pharmaceutical warehouse. ~300 employees in Poland.